We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Chip with LC/MS Performs Small Molecule Analysis

By HospiMedica staff writers
Posted on 07 Mar 2007
Use of a high-performance liquid chromatography (HPLC) chip has been expanded to its triple quadrupole (QQQ) and quadrupole-time of flight (Q-TOF) mass spectrometers. More...


Smaller than a credit card, the chip integrates the sample enrichment and separation capability of a nanoflow liquid chromatography (LC) system with the single emitter per instrument and intricate connections used for electrospray mass spectrometry. The technology eliminates 50% of the fittings and connections typically required in nanoflow liquid chromatography/mass spectrometry (LC/MS) systems, dramatically reducing the possibility of leaks and dead volumes, and significantly improving ease-of-use, sensitivity, productivity, and reliability during analysis.

This HPLC chip technology, developed by Agilent Technologies (Palo Alto, CA, USA), is an innovative form of liquid chromatography separation that replaces conventional LC nanoflow column and microvalves with a simple, compact microfluidics chip. It enables both chip/mass spectrometer systems to perform small molecule analysis and completes the chip's expansion across Agilent's entire LC/MS portfolio.

Smaller than a credit card, the chip integrates the sample enrichment and separation capability of a nanoflow LC system with the single emitter per instrument and intricate connections used for electrospray mass spectrometry. The technology eliminates 50% of the fittings and connections typically required in nanoflow LC/MS systems, dramatically reducing the possibility of leaks and dead volumes, and significantly improving ease-of-use, sensitivity, productivity and reliability during analysis.

Agilent's HPLC Chip technology delivers stable, reproducible nanospray, critical for high-sensitivity quantitative QQQ applications for small molecules. The expansion announced enables researchers to move beyond the HPLC chip's early protein-identification applications to the small molecule arena.

Where sample size is limited, quantitative nanospray on the QQQ in particular will offer special opportunities, providing substantial savings to customers in sample preparation alone, said Agilent's Fred Strohmeier, vice president and general manager, liquid phase separations division. It will have special use for life sciences, environmental and forensic applications, where researchers often deal with low amounts of sample. For these applications, conventional nanospray isn't reliable enough for routine use and is difficult to implement and maintain. With the HPLC chip, in combination with Agilent's LC/MS portfolio, it's finally accessible for these applications--and in a remarkably easy-to-use format.


Related Links:
Agilent

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.